Medscape

Filtered Pump Sets and Flolan (Epoprostenol) Interruption

Epoprostenol (FLOLAN) is an intravenous medication used to treat primary pulmonary hypertension (PPH), a condition characterized by progressive increases in pulmonary artery pressure, leading to right ...
Medscape

Epoprostenol improves survival in primary pulmonary hypertension

Dallas, TX - As new agents are developed for the treatment of primary pulmonary hypertension (PPH), long-term data are now becoming available on the first drug approved for this indication, ...
Business Wire

GlaxoSmithKline and Myogen Announce Pulmonary Arterial Hypertension Partnership; GlaxoSmithKline to Commercialize Ambrisentan in All Territories Outside of the U.S.

Myogen Receives Flolan Rights in U.S. and Will Launch Commercial Operations in Q2 '06 GlaxoSmithKline (LSE: GSK) (NYSE: GSK) and Myogen, Inc. (Nasdaq: MYOG) today announced a two-part collaboration in ...
BioWorld

UTC's Remodulin Approved; Product Hits Market Running

Although it must conduct a Phase IV trial, United Therapeutics Corp. received FDA approval to market Remodulin for the treatment of pulmonary arterial hypertension in patients with New York Heart ...
EurekAlert!

First oral drug proven effective in treating primary pulmonary hypertension

A first-of-its-kind oral drug has been shown to successfully treat primary pulmonary hypertension (PPH), according to the results of a multi-center trial led by UCSD School of Medicine pulmonary ...